fda
10 records
FDA Drug Recall: BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 25
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: HCG (CHORIONIC GONADOTROPIN 1000 IU/ML PEP 25 mg/mL) inj 5 mL multidose vial co
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL Alprostadil 2
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 25
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE V
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Lipoplex (METHIONINE 25 MG/ML INOSITOL 50 MG/ML CHOLINE CHLORIDE 50 MG/ML HYDROX
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL MDV Compounded. C
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE V
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
FDA Drug Recall: TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostad
2019-05-08
Class II — Lack of assurance of sterility for injectables and solutions intended to be sterile.
View Source
nppes
1 records
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.